The Cardiovascular Risk Associated with the Use of Long Acting Bronchodilators

It seems the pendulum is always swinging back and forth with the management of COPD. Few years ago, we have pulled away from the use of high dose inhaled corticosteroids when we found its association with increased risk of pneumonia and related mortalities. Here’s my post on this topic. And thus, the treatment strategy has shifted to using more long acting bronchodilators. These bronchodilators include LABA (long acting beta agonist) and LAMA (long acting muscarinic antagonist).

Continue reading The Cardiovascular Risk Associated with the Use of Long Acting Bronchodilators

Advertisements

Pharmacological Treatment for Alcohol Use Disorder

The American Psychiatry Association has just released new practice guidelines for the pharmacological treatment of patients with alcohol use disorder. For the full guidelines, click here.  In this guideline, the use of these 5 agents have been discussed: naltrexone, acamprosate, disulfiram, topiramate and gabapentin.

Continue reading Pharmacological Treatment for Alcohol Use Disorder

Opioid Withdrawal Symptoms – “Oozing from the Orifices”

I am happy to see some of my patients’ opioid therapies being tapered down. Last week, I went to a talk on Opioid Use Disorder. The speaker described the opioid withdrawal symptoms as “oozing from the orifices”.  I agree this description wholeheartedly! When opioids are tapered too quickly, it can cause tearing eyes, runny nose and diarrhea…..

Continue reading Opioid Withdrawal Symptoms – “Oozing from the Orifices”

How will Drug coverage change on Jan 1 2018 for Children and Youth?

If you live in Ontario, OHIP Plus will be effective as of Jan 1, 2018 which means the Ontario Drug Benefits Program will pay for a number of prescription medications for anyone below the age of 25. So what do you really need to know?

Continue reading How will Drug coverage change on Jan 1 2018 for Children and Youth?

Direct-to-Consumer Advertising or Public Health Awareness?

Recently, many primary health providers have been bombarded with questions about the latest shingles vaccine, Shringrix made by GlaxoSmithKline.

Continue reading Direct-to-Consumer Advertising or Public Health Awareness?

6 Things Pharmacists and Patients Should Question – Choosing Wisely Canada

Pharmacists have finally developed the following 6 things to question in partnership with Choosing Wisely Canada:

Continue reading 6 Things Pharmacists and Patients Should Question – Choosing Wisely Canada